Form 4: DarioHealth Director Shaked Acquires 20,000 Shares

DarioHealth Corp. Director Yoav Shaked reported the acquisition of 20,000 shares of common stock on September 11, 2025, as a restricted share award.

Summary

• Yoav Shaked, a Director of DarioHealth Corp. (DRIO), reported a change in beneficial ownership.
• On September 11, 2025, Shaked acquired 20,000 shares of Common Stock.
• The acquisition was a restricted share award with a price of $0 per share.
• These shares will vest in two equal installments on the last day of each successive annual anniversary over a two-year period.
• Following this transaction, Shaked directly beneficially owns 32,810 shares of Common Stock.
• An additional 84 shares are indirectly beneficially owned by his spouse, for which Shaked disclaims beneficial ownership.
• The reported share numbers reflect a 20-for-1 reverse stock split effected on August 28, 2025.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even as a restricted award, generally signals confidence in the company's future. The reverse stock split, while potentially a sign of previous low share price, is a completed action reflected in the current share count, and the award itself is a positive incentive.

Positives

• Director Yoav Shaked acquired 20,000 shares of common stock, indicating continued alignment with shareholder interests.
• The acquisition is a restricted share award, often used to incentivize long-term performance and retention of key personnel.

Risks

• The restricted share award is subject to a vesting schedule, meaning the shares are not fully owned until the vesting conditions are met over a two-year period.

Future Outlook

The restricted share award is structured to vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period, indicating a future commitment and incentive structure for the director.

Management Comments

• The reporting person disclaims beneficial ownership of the 84 shares held by his spouse, stating that the report shall not be deemed an admission of beneficial ownership for Section 16 or any other purpose.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, common across all publicly traded companies. Restricted stock awards are a standard compensation tool in many industries, aligning management incentives with long-term company performance. The reverse stock split, while not directly detailed in its rationale here, is a corporate action often undertaken to increase share price, meet listing requirements, or improve market perception, which can be observed across various sectors.

Comparison to Industry Standards

• Restricted stock awards with multi-year vesting schedules are a common practice for director compensation in publicly traded companies, aligning executive interests with long-term shareholder value.
• The $0 acquisition price is typical for such grants.
• The 20-for-1 reverse stock split is a significant corporate action, and while the filing doesn't provide context, such splits are often implemented by companies across various industries to boost share price, improve liquidity, or meet exchange listing requirements.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director may be viewed positively as it aligns management's interests with shareholder value. The reverse stock split impacts the number of shares outstanding and per-share metrics.
• Management/Employees: The restricted share award serves as an incentive for the director, potentially enhancing retention and performance.

Next Steps

• The restricted shares will vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction where a director received a restricted stock award. While the acquisition of shares by a director is generally a positive signal of confidence, the filing itself does not provide sufficient financial or operational details to warrant a 'buy' or 'sell' recommendation. The reverse stock split has already been effected and is reflected in the reported share count. Investors should consider this information in conjunction with the company's broader financial performance and strategic outlook.

Keywords

DarioHealth Corp., DRIO, Yoav Shaked, Form 4, Insider Trading, Stock Acquisition, Restricted Stock, Director, Reverse Stock Split